Apoglyx

Lund, Sweden

Apoglyx is a pre-clinical stage virtual biotech company with the aim to develop an oral therapy for type 2 diabetes patients.

$697K raised

Oct 2021

Venture - Series Unknown

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Apoglyx raised?

Apoglyx has raised $697K in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in October 2021.

Who are Apoglyx's investors?

Apoglyx's investors include Almi Invest, LU Innovation.

Where is Apoglyx headquartered?

Apoglyx is headquartered in Lund, Sweden.

What does Apoglyx do?

Apoglyx is a pre-clinical stage virtual biotech company with the aim to develop an oral therapy for type 2 diabetes patients.

What stage is Apoglyx at?

Apoglyx is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated October 25, 2021.

MLA

"Apoglyx — Funding & Investors." VCBacked, October 25, 2021, https://www.vcbacked.co/company/apoglyx. Accessed July 2, 2026.

APA

VCBacked. (2021). Apoglyx — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/apoglyx

Wikipedia (cite web)

{{cite web |title=Apoglyx — Funding & Investors |url=https://www.vcbacked.co/company/apoglyx |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated October 25, 2021.